Application Information

This drug has been submitted to the FDA under the reference 040118/001.

Names and composition

"CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE" is the commercial name of a drug composed of ASPIRIN and CARISOPRODOL and CODEINE PHOSPHATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
040118/001 CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET/ORAL 325MG and 200MG and 16MG
040283/001 CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET/ORAL 325MG and 200MG and 16MG
040860/001 CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET/ORAL 325MG and 200MG and 16MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
012366/002 SOMA COMPOUND W/ CODEINE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET/ORAL 325MG and 200MG and 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
040118/001 CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET/ORAL 325MG and 200MG and 16MG
040283/001 CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET/ORAL 325MG and 200MG and 16MG
040860/001 CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET/ORAL 325MG and 200MG and 16MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved